IDNNA

Last updated
IDNNA
IDNNA.png
Clinical data
Other names4-Iodo-2,5-dimethoxy-N,N-dimethylamphetamine; 2,5-Dimethoxy-4-iodo-N,N-dimethylamphetamine; N,N-Dimethyl-DOI
Routes of
administration 		Oral [1]
ATC code
  • None
Pharmacokinetic data
Duration of action Unknown [1]
Identifiers
  • 1-(4-iodo-2,5-dimethoxyphenyl)-N,N-dimethylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C13H20INO2
Molar mass 349.212 g·mol−1
3D model (JSmol)
  • Ic1cc(OC)c(cc1OC)CC(N(C)C)C
  • InChI=1S/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 Yes check.svgY
  • Key:XBCUSBRGRALQID-UHFFFAOYSA-N Yes check.svgY
   (verify)

IDNNA, also known as 4-iodo-2,5-dimethoxy-N,N-dimethylamphetamine or as N,N-dimethyl-DOI, is a lesser-known psychoactive drug and a substituted amphetamine. [1] It is also the N,N-dimethyl analogue of DOI. [1]

Contents

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), the minimum dose is listed as 2.6 mg and the duration as unknown. [1] IDNNA produces few to no effects. [1]

Society and culture

Canada

IDNNA is a controlled substance in Canada under phenethylamine blanket-ban language. [2]

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act. [3]

See also

References

  1. 1 2 3 4 5 6 IDNNA Entry in PiHKAL
  2. ↑ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
  3. ↑ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.